RT Journal Article
SR Electronic
T1 Ca2+-Calmodulin and Janus Kinase 2 Are Required for Activation of Sodium-Proton Exchange by the Gi-Coupled 5-Hydroxytryptamine1a Receptor
JF Journal of Pharmacology and Experimental Therapeutics
JO J Pharmacol Exp Ther
FD American Society for Pharmacology and Experimental Therapeutics
SP 314
OP 322
DO 10.1124/jpet.106.112581
VO 320
IS 1
A1 Justin H. Turner
A1 Maria N. Garnovskaya
A1 Sonya D. Coaxum
A1 Tamara M. Vlasova
A1 Margarita Yakutovich
A1 David M. Lefler
A1 John R. Raymond
YR 2007
UL http://jpet.aspetjournals.org/content/320/1/314.abstract
AB The type 1 sodium-proton exchanger (NHE-1) is expressed ubiquitously and regulates key cellular functions, including mitogenesis, cell volume, and intracellular pH. Despite its importance, the signaling pathways that regulate NHE-1 remain incompletely defined. In this work, we present evidence that stimulation of the 5-hydroxytryptamine1A (5-HT1A) receptor results in the formation of a signaling complex that includes activated Janus kinase 2 (Jak2), Ca2+/calmodulin (CaM), and NHE-1, and which involves tyrosine phosphorylation of CaM. The signaling pathway also involves rapid agonist-induced association of CaM and NHE-1 as assessed by coimmunoprecipitation studies and by bioluminescence resonance energy transfer studies in living cells. We propose that NHE-1 is activated through this pathway: 5-HT1A receptor → Gi2α and/or Gi3α → Jak2 activation → tyrosine phosphorylation of CaM → increased binding of CaM to NHE-1 → induction of a conformational change in NHE-1 that unmasks an obscured proton-sensing and/or proton-transporting region of NHE-1 → activation of NHE-1. The Gi/o-coupled 5-HT1A receptor now joins a handful of Gq-coupled receptors and hypertonic shock as upstream activators of this emerging pathway. In the course of this work, we have presented clear evidence that CaM can be activated through tyrosine phosphorylation in the absence of a significant role for elevated intracellular Ca2+. We have also shown for the first time that the association of CaM with NHE-1 in living cells is a dynamic process. The American Society for Pharmacology and Experimental Therapeutics